Proteome Sciences plc (PMSNF)
USD 0.02
(0.0%)
USD 0.02
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 17.15 Million USD | 19.04% |
| 2022 | 14.41 Million USD | -8.79% |
| 2021 | 15.79 Million USD | 4.71% |
| 2020 | 15.08 Million USD | 5.01% |
| 2019 | 14.36 Million USD | 13.54% |
| 2018 | 12.65 Million GBP | 2.66% |
| 2017 | 12.32 Million GBP | 9.79% |
| 2016 | 11.22 Million GBP | -15.82% |
| 2015 | 13.33 Million GBP | 62.79% |
| 2014 | 8.19 Million GBP | 3.04% |
| 2013 | 7.95 Million GBP | 18.22% |
| 2012 | 6.72 Million GBP | 3.06% |
| 2011 | 6.52 Million GBP | 3.05% |
| 2010 | 6.33 Million GBP | -46.27% |
| 2009 | 11.78 Million GBP | 29.7% |
| 2008 | 9.08 Million GBP | 53.07% |
| 2007 | 5.93 Million GBP | 263.12% |
| 2006 | 1.63 Million GBP | 0.0% |
| 2005 | - GBP | 0.0% |
| 2004 | - GBP | -100.0% |
| 2003 | 34 Thousand GBP | -66.0% |
| 2002 | 100 Thousand GBP | -45.36% |
| 2001 | 183 Thousand GBP | -54.48% |
| 2000 | 402 Thousand GBP | 538.1% |
| 1999 | 63 Thousand GBP | 173.91% |
| 1998 | 23 Thousand GBP | 2200.0% |
| 1997 | 1000.00 GBP | -95.0% |
| 1996 | 20 Thousand GBP | -48.72% |
| 1995 | 39 Thousand GBP | 0.0% |
| 1994 | - GBP | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 15.86 Million USD | 0.0% |
| 2023 Q4 | 17.15 Million USD | 9.28% |
| 2023 Q3 | 15.69 Million GBP | 9.54% |
| 2023 Q1 | 13.57 Million GBP | -5.78% |
| 2023 FY | 17.15 Million USD | 19.04% |
| 2023 Q2 | 14.32 Million USD | 5.53% |
| 2022 Q3 | 12.97 Million GBP | -8.77% |
| 2022 Q2 | 14.21 Million GBP | -5.68% |
| 2022 Q4 | 14.41 Million USD | 11.1% |
| 2022 Q1 | 15.07 Million GBP | -4.58% |
| 2022 FY | 14.41 Million USD | -8.79% |
| 2021 Q3 | 15.39 Million GBP | 0.49% |
| 2021 Q1 | 14.72 Million GBP | -2.39% |
| 2021 FY | 15.79 Million USD | 4.71% |
| 2021 Q4 | 15.79 Million GBP | 2.6% |
| 2021 Q2 | 15.32 Million GBP | 4.04% |
| 2020 Q3 | 14.07 Million GBP | 3.97% |
| 2020 Q1 | 12.96 Million GBP | -9.75% |
| 2020 Q2 | 13.53 Million GBP | 4.37% |
| 2020 Q4 | 15.08 Million GBP | 7.22% |
| 2020 FY | 15.08 Million USD | 5.01% |
| 2019 Q2 | 12.85 Million GBP | -2.28% |
| 2019 FY | 14.36 Million USD | 13.54% |
| 2019 Q1 | 13.15 Million GBP | 32.35% |
| 2019 Q4 | 14.36 Million GBP | 13.87% |
| 2019 Q3 | 12.61 Million GBP | -1.81% |
| 2018 FY | 12.65 Million GBP | 2.66% |
| 2018 Q2 | 9.09 Million GBP | -28.73% |
| 2018 Q1 | 12.76 Million GBP | 40.06% |
| 2018 Q3 | 12.94 Million GBP | 42.36% |
| 2018 Q4 | 9.93 Million GBP | -23.27% |
| 2017 Q4 | 9.11 Million GBP | -23.98% |
| 2017 Q3 | 11.98 Million GBP | 34.19% |
| 2017 Q2 | 8.93 Million GBP | -20.19% |
| 2017 FY | 12.32 Million GBP | 9.79% |
| 2017 Q1 | 11.19 Million GBP | 23.17% |
| 2016 Q1 | 12.7 Million GBP | 40.37% |
| 2016 Q4 | 9.08 Million GBP | -20.95% |
| 2016 Q2 | 8.81 Million GBP | -30.57% |
| 2016 FY | 11.22 Million GBP | -15.82% |
| 2016 Q3 | 11.49 Million GBP | 30.33% |
| 2015 Q4 | 9.04 Million GBP | -32.27% |
| 2015 Q1 | 12.35 Million GBP | 50.8% |
| 2015 FY | 13.33 Million GBP | 62.79% |
| 2015 Q3 | 13.36 Million GBP | 60.65% |
| 2015 Q2 | 8.31 Million GBP | -32.69% |
| 2014 Q3 | 13.29 Million GBP | 64.69% |
| 2014 FY | 8.19 Million GBP | 3.04% |
| 2014 Q2 | 8.07 Million GBP | -40.0% |
| 2014 Q1 | 13.45 Million GBP | 69.18% |
| 2014 Q4 | 8.19 Million GBP | -38.35% |
| 2013 FY | 7.95 Million GBP | 18.22% |
| 2013 Q2 | 7.83 Million GBP | -34.14% |
| 2013 Q1 | 11.89 Million GBP | 76.83% |
| 2013 Q4 | 7.95 Million GBP | -38.23% |
| 2013 Q3 | 12.87 Million GBP | 64.36% |
| 2012 Q4 | 6.72 Million GBP | 0.0% |
| 2012 FY | 6.72 Million GBP | 3.06% |
| 2012 Q2 | 6.62 Million GBP | 0.0% |
| 2011 FY | 6.52 Million GBP | 3.05% |
| 2011 Q4 | 6.52 Million GBP | 0.0% |
| 2011 Q2 | 6.42 Million GBP | 0.0% |
| 2010 Q4 | 6.33 Million GBP | 0.0% |
| 2010 Q2 | 7.75 Million GBP | 0.0% |
| 2010 FY | 6.33 Million GBP | -46.27% |
| 2009 Q2 | 10.67 Million GBP | 0.0% |
| 2009 FY | 11.78 Million GBP | 29.7% |
| 2009 Q4 | 11.78 Million GBP | 0.0% |
| 2008 FY | 9.08 Million GBP | 53.07% |
| 2008 Q4 | 9.08 Million GBP | 0.0% |
| 2008 Q2 | 6.58 Million GBP | 0.0% |
| 2007 Q2 | 3.73 Million GBP | 0.0% |
| 2007 FY | 5.93 Million GBP | 263.12% |
| 2007 Q4 | 5.93 Million GBP | 0.0% |
| 2006 Q4 | 1.63 Million GBP | 0.0% |
| 2006 Q2 | - GBP | 0.0% |
| 2006 FY | 1.63 Million GBP | 0.0% |
| 2005 Q2 | - GBP | 0.0% |
| 2005 Q4 | - GBP | 0.0% |
| 2005 FY | - GBP | 0.0% |
| 2004 Q2 | - GBP | 0.0% |
| 2004 Q4 | - GBP | 0.0% |
| 2004 FY | - GBP | -100.0% |
| 2003 FY | 34 Thousand GBP | -66.0% |
| 2002 FY | 100 Thousand GBP | -45.36% |
| 2001 FY | 183 Thousand GBP | -54.48% |
| 2000 FY | 402 Thousand GBP | 538.1% |
| 1999 FY | 63 Thousand GBP | 173.91% |
| 1998 FY | 23 Thousand GBP | 2200.0% |
| 1997 FY | 1000.00 GBP | -95.0% |
| 1996 FY | 20 Thousand GBP | -48.72% |
| 1995 FY | 39 Thousand GBP | 0.0% |
| 1994 FY | - GBP | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| American Bio Medica Corporation | 2.24 Million USD | -665.789% |
| Arrayit Corporation | 1.07 Million USD | -1491.004% |
| Atlantic International Corp. | 2.93 Million USD | -485.352% |
| Biocept, Inc. | 12.1 Million USD | -41.661% |
| Bioqual, Inc. | 3.58 Million USD | -378.22% |
| CardioGenics Holdings Inc | 72.61 Thousand USD | -23523.096% |
| DermTech, Inc. | 54.39 Million USD | 68.464% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 471.86 Million USD | 96.365% |
| HTG Molecular Diagnostics, Inc. | 4.83 Million USD | -254.858% |
| iMD Companies, Inc. | 1.12 Million USD | -1431.374% |
| IDenta Corp. | 789.14 Thousand USD | -2073.701% |
| Interpace Biosciences, Inc. | 11.19 Million USD | -53.267% |
| Integrative Health Technologies, Inc. | - USD | -Infinity% |
| InVitro International | 43.84 Thousand USD | -39023.446% |
| Lumos Diagnostics Holdings Limited | 8.04 Million USD | -113.224% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 3.82 Million USD | -348.358% |
| NovelStem International Corp. | 3.57 Million USD | -379.877% |
| Optigenex Inc. | 8.94 Million USD | -91.86% |
| PharmChem, Inc. | 77.35 Thousand USD | -22075.837% |
| Response Genetics, Inc | 6.37 Million USD | -169.162% |
| Rennova Health, Inc. | 15.32 Million USD | -11.901% |
| RushNet, Inc. | 4.82 Million USD | -255.657% |
| ScreenPro Security Inc. | 207.03 Thousand USD | -8185.439% |
| Stella Diagnostics Inc. | 6.2 Million USD | -176.642% |
| StageZero Life Sciences Ltd. | 1.8 Million USD | -852.938% |
| Todos Medical Ltd. | 38.34 Million USD | 55.268% |